Report #2830654

Received Mar 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: Jan 8, 2025
Onset: Jan 9, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Influenza like illness

Symptom narrative

Flu like symptoms; This non-serious case was reported by a consumer via sales rep and described the occurrence of influenza-like symptoms in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On 08-JAN-2025, the patient received the 1st dose of Shingrix. On 09-JAN-2025, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: Flu like symptoms). The outcome of the influenza-like symptoms was resolved. The reporter considered the influenza-like symptoms to be related to Shingrix. The company considered the influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 04-MAR-2025 The patient experienced flu like symptoms, joint pain and headache after the first dose of Shingrix.